Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-07-07

Clinical Trial Update: Examining the Impact of Sirolimus on Ketamine's Antidepressant Effects [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating how sirolimus influences the antidepressant effects of ketamine; study completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)
  • Sirolimus (Sirolimus)

Snippet

Sponsor: Yale University | Conditions: Depression | Phase 2 | Status: COMPLETED | Results posted: 2020-07-07